Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants
Thandeka Moyo-Gwete, Mashudu Madzivhandila, Nonhlanhla N. Mkhize, et al.
Journal of Virology (2022) Vol. 96, Iss. 15
Open Access | Times Cited: 13

Showing 13 citing articles:

Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
SARS-CoV-2 spike protein in infectivity
Alaa Muayad Altaie, Rania Hamdy, Mohamed I. Husseiny, et al.
Elsevier eBooks (2025), pp. 21-56
Closed Access
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
Georgia Deliyannis, Nicholas A. Gherardin, Chinn Yi Wong, et al.
EBioMedicine (2023) Vol. 92, pp. 104574-104574
Open Access | Times Cited: 13
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant
Simone I. Richardson, Prudence Kgagudi, Nelia P. Manamela, et al.
Cell Reports Medicine (2022) Vol. 4, Iss. 1, pp. 100910-100910
Open Access | Times Cited: 15
Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
Janice Zhirong Jia, Chee Wah Tan, Samuel M. S. Cheng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 12
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity
Simone I. Richardson, Nonkululeko Mzindle, Thopisang Motlou, et al.
Journal of Virology (2024) Vol. 98, Iss. 7
Closed Access | Times Cited: 1
A trimeric spike-based COVID-19 vaccine candidate induces broad neutralization against SARS-CoV-2 variants
Feixia Gao, Mei Zheng, Jiangfeng Fan, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 4
SARS-CoV-2 BA.4 infection triggers more cross-reactive neutralizing antibodies than BA.1
Simone I. Richardson, Thopisang Motlou, Mieke A. van der Mescht, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates
Xiaoli Feng, Dandan Yu, Mi Zhang, et al.
Virologica Sinica (2022) Vol. 37, Iss. 6, pp. 804-812
Open Access | Times Cited: 6
Preclinical Evaluation of a Cross-Protective ß-SARS-CoV-2 Virus-Like Particle Vaccine Adjuvanted with MF59
Linda Earnest, Daniel Fernandez‐Ruiz, Melissa A. Edeling, et al.
(2024)
Open Access
Diverse BCR usage and T cell activation induced by different COVID-19 sequential vaccinations
Junxiang Wang, Kaiyi Li, Yuan Wang, et al.
mBio (2024) Vol. 15, Iss. 10
Open Access
Preclinical evaluation of a cross-protective ß-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
Joseph Torresi, Linda Earnest, Daniel Fernandez‐Ruiz, et al.
Research Square (Research Square) (2024)
Open Access
Cross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vaccines
Sabrina E. Vinzón, María V. López, Eduardo G. Cafferata, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Page 1

Scroll to top